Trimeris' IPO

Trimeris raised a round of funding on October 10, 1997. Investors include Public.

Trimeris is a development stage, biopharmaceutical company engaged in the discovery and development of novel therapeutic agents that block viral infection by inhibiting viral fusion with host cells. T…

Articles about Trimeris' IPO: